ZFHX4 and central nervous system cancer: This ZFHX4/SOX2 regulatory circuit likely serves to amplify and stabilize the pro-malignancy signals initiated by ZFHX4-AS1, effectively “locking” glioma cells into a highly aggressive phenotype and offering a more nuanced understanding of glioma’s relentless progression.